Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Annals of Clinical and Laboratory Science|July 2, 2017
Synergy between Paclitaxel and Anti-Cancer Peptide PNC-27 in the Treatment of Ovarian CancerIoannis Alagkiozidis, Constantine Gorelick, Tana Shah, et al.International Journal of Molecular Sciences|June 4, 2020
Arginine Vasopressin Modulates Ion and Acid/Base Balance by Regulating Cell Numbers of Sodium Chloride Cotransporter and H+-ATPase Rich IonocytesSok-Keng Tong, Hung-Ling Lee, Yi-Chun Lee, et al.Scientific Reports|July 8, 2021
Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancerRachelle P Mendoza, Tahmineh Haidary, Elmer Gabutan, et al.Journal of the American Chemical Society|April 1, 2025
Adapting Atomic Configuration Steers Dynamic Half-Occupied State for Efficient CO2 Electroreduction to COJiali Wang, Hui Ying Tan, Chia-Shuo Hsu, et al.The American Journal of Pathology|June 6, 2009
Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancerJian-Ping Guo, Shao-Kun Shu, Lili He, et al.Annals of Clinical and Laboratory Science|December 15, 2015
Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian CancerEhsan Sarafraz-Yazdi, Constantine Gorelick, Allison R Wagreich, et al.Obstetrics and Gynecology|September 2, 2005
Outcome after negative colposcopy among human immunodeficiency virus-infected women with borderline cytologic abnormalitiesL Stewart Massad, Charlesnika T Evans, Howard D Strickler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2014
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group studyPaul A DiSilvestro, Shamshad Ali, Peter S Craighead, et al.Cancer|July 31, 2020
COVID-19 outcomes of patients with gynecologic cancer in New York CityOlivia D Lara, Roisin E O'Cearbhaill, Maria J Smith, et al.Gynecologic Oncology|October 6, 2020
Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infectionMaria Smith, Olivia D Lara, Roisin O'Cearbhaill, et al.Pageof 8